The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice

References

• Brand RE, Tempero MA. Pancreatic cancer. Curr Opin Oncol 1998;10:362–6.
   PubMedGoogle Scholar
• Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Cancer statistics, 2006. CA Cancer J Clin 2006;56:106–30.
   PubMed Web of Science ®Google Scholar
• Hidalgo M. Pancreatic cancer. N Engl J Med 2010;362:1605–17.
   PubMed Web of Science ®Google Scholar
• Apte MV, Park S, Phillips PA, Santucci N, Goldstein D, Kumar RK, Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas 2004;29:179–87.
   PubMed Web of Science ®Google Scholar
• Bachem MG, Schünemann M, Ramadani M, Siech M, Beger H, Buck A, Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 2005;128:907–21.
   PubMed Web of Science ®Google Scholar
• Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 2008;68:918–26.
   PubMed Web of Science ®Google Scholar
• Vonlaufen A, Joshi S, Qu C, Phillips PA, Xu Z, Parker NR, Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res 2008;68:2085–93.
   PubMed Web of Science ®Google Scholar
• Vonlaufen A, Joshi S, Qu C, Phillips PA, Xu Z, Parker NR, Role of pancreatic stellate cells in pancreatic cancer metastasis. Am J Pathol 2010;177:2585–96.
   Google Scholar
• Omary MB, Lugea A, Lowe AW, Pandol SJ. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 2007;117:50–9.
   PubMed Web of Science ®Google Scholar
• Masamune A, Shimosegawa T. Signal transduction in pancreatic stellate cells. J Gastroenterol 2009;44:249–60.
   PubMed Web of Science ®Google Scholar
• Masamune A, Watanabe T, Kikuta K, Shimosegawa T. Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin Gastroenterol Hepatol 2009;7:S48–54.
   PubMed Web of Science ®Google Scholar
• Erkan M, Adler G, Apte MV, Bachem MG, Buchholz M, Detlefsen S, StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut 2012;61:172–8.
   PubMed Web of Science ®Google Scholar
• Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009;324:1457–61.
   PubMed Web of Science ®Google Scholar
• Erkan M, Hausmann S, Michalski CW, Fingerle AA, Dobritz M, Kleeff J, The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol 2012;9:454–67.
   PubMed Web of Science ®Google Scholar
• Feig C, Gopinathan A, Neesse A, Chan DS, Cook N, Tuveson DA. The pancreas cancer microenvironment. Clin Cancer Res 2012;18:4266–76.
   PubMed Web of Science ®Google Scholar
• Kuno A, Yamada T, Masuda K, Ogawa K, Sogawa M, Nakamura S, Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Gastroenterology 2003;124:1010–19.
   PubMed Web of Science ®Google Scholar
• Yamada T, Kuno A, Masuda K, Ogawa K, Sogawa M, Nakamura S, Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J Pharmacol Exp Ther 2003;307:17–23.
   PubMed Web of Science ®Google Scholar
• Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 2004;43:993–1002.
   PubMed Web of Science ®Google Scholar
• Masamune A, Kikuta K, Watanabe T, Satoh K, Hirota M, Hamada S, Fibrinogen induces cytokine and collagen production in pancreatic stellate cells. Gut 2009;58:550–9.
   PubMed Web of Science ®Google Scholar
• Hamada S, Masamune A, Takikawa T, Suzuki N, Kikuta K, Hirota M, Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells. Biochem Biophys Res Commun 2012;421:349–54.
   PubMed Web of Science ®Google Scholar
• Dolber PC, Spach MS. Conventional and confocal fluorescence microscopy of collagen fibers in the heart. J Histochem Cytochem 1993;41:465–9.
   PubMed Web of Science ®Google Scholar
• Masamune A, Watanabe T, Kikuta K, Satoh K, Kanno A, Shimosegawa T. Nuclear expression of interleukin-33 in pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2010;299:G821–2.
   Web of Science ®Google Scholar
• Yuan Z, Nimata M, Okabe TA, Shioji K, Hasegawa K, Kita T, Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure. Am J Physiol Heart Circ Physiol 2005;289:H1147–52.
   Google Scholar
• Wakui H, Tamura K, Tanaka Y, Matsuda M, Bai Y, Dejima T, Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice. Hypertension 2010;55:1157–64.
   Google Scholar
• Kikuta K, Masamune A, Watanabe T, Ariga H, Itoh H, Hamada S, Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells. Biochem Biophys Res Commun 2010;403:380–4.
   PubMed Web of Science ®Google Scholar
• Mantoni TS, Lunardi S, Al-Assar O, Masamune A, Brunner TB. Pancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signaling. Cancer Res 2011;71:3453–8.
   Google Scholar
• Arafat HA, Gong Q, Chipitsyna G, Rizvi A, Saa CT, Yeo CJ. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. J Am Coll Surg 2007;204:996–1005.
   PubMed Web of Science ®Google Scholar
• Gong Q, Davis M, Chipitsyna G, Yeo CJ, Arafat HA. Blocking angiotensin II type 1 receptor triggers apoptotic cell death in human pancreatic cancer cells. Pancreas 2010;39:581–94.
   Google Scholar
• Noguchi R, Yoshiji H, Ikenaka Y, Namisaki T, Kitade M, Kaji K, Synergistic inhibitory effect of gemcitabine and angiotensin type-1 receptor blocker, losartan, on murine pancreatic tumor growth via anti-angiogenic activities. Oncol Rep 2009;22:355–60.
   PubMed Web of Science ®Google Scholar
• Reinehr R, Zoller S, Klonowski-Stumpe H, Kordes C, Häussinger D. Effects of angiotensin II on rat pancreatic stellate cells. Pancreas 2004;28:129–37.
   Google Scholar
• Liu WB, Wang XP, Wu K, Zhang RL. Effects of angiotensin II receptor antagonist, losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells. World J Gastroenterol 2005;11:6489–94.
   Web of Science ®Google Scholar
• Ko SH, Hong OK, Kim JW, Ahn YB, Song KH, Cha BY. High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin–angiotensin system. J Cell Biochem 2006;98:343–55.
   PubMed Web of Science ®Google Scholar
• Erkan M, Reiser-Erkan C, Michalski CW, Kong B, Esposito I, Friess H, The impact of the activated stroma on pancreatic ductal adenocarcinoma biology and therapy resistance. Curr Mol Med 2012;12:288–303.
   PubMed Web of Science ®Google Scholar
• Feig C, Gopinathan A, Neesse A, Chan DS, Cook N, Tuveson DA. The pancreas cancer microenvironment. Clin Cancer Res 2012;18:4266–76.
   PubMed Web of Science ®Google Scholar
• Leung PS. The physiology of a local renin–angiotensin system in the pancreas. J Physiol 2007;580:31–7.
   PubMedGoogle Scholar
• Nakai Y, Isayama H, Ijichi H, Sasaki T, Sasahira N, Hirano K, Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine. Br J Cancer 2010;103:1644–8.
   PubMed Web of Science ®Google Scholar